NCT07034794View on ClinicalTrials.gov

A Clinical Trial to Examine Lysoveta on Cognitive Function in Healthy Adults With Self-perceived Memory Problems

NANot yet recruitingINTERVENTIONAL
Enrollment

138

Participants

Timeline

Start Date

October 31, 2025

Primary Completion Date

July 31, 2026

Study Completion Date

July 31, 2026

Conditions
HealthyMemory Problems
Interventions
DIETARY_SUPPLEMENT

Lysoveta

The Lysoveta capsules contain 500 mg of lysophosphatidylcholine-rich oil extract of Antarctic krill.

OTHER

Placebo

The placebo capsules contain medium-chain triglyceride (MCT) oil, maize oil, olive oil, and palm kernel oil.

Trial Locations (1)

N6B3L1

KGK Science Inc., London

Sponsors

Collaborators (1)

KGK Science Inc.
All Listed Sponsors
collaborator

KGK Science Inc.

INDUSTRY

lead

Aker BioMarine Human Ingredients AS

INDUSTRY

NCT07034794 - A Clinical Trial to Examine Lysoveta on Cognitive Function in Healthy Adults With Self-perceived Memory Problems | Biotech Hunter | Biotech Hunter